Skip to main navigation

Company
Science
Pipeline
Clinical Trials
- Clinical Trials Overview
Careers
- Job Opportunities
- Our Culture
Investors & Media

Select Page

Press Releases

Press Releases

Year

Jan 09, 2025

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions

Media & IR Contact

Investor Relations & Media Contact

Robin Garner
Investor Relations
Contact Us

Helpful Tools

Print Page
Email Alerts
RSS Feeds

Company

About Us
Leadership
Partnering
Contact

Science

Discovery Platform
Therapeutic Focus
Scientific References

Pipeline

Development Pipeline
Camonsertib ATR Inhibitor
Lunresertib PKMYT1 Inhibitor
Polθ Inhibitor

Clinical Trials

Clinical Trials Overview

Careers

Job Opportunities
Our Culture

Investors & Media

Corporate Profile
Press Releases
Events & Presentations
Stock Information
SEC Filings
Corporate Governance
Investor Resources

© 2025 Repare Therapeutics

Privacy Policy
Terms of Use
Cookie Policy